RDY
$13.26+1.38%
as of close, Oct 20, 2026
☾ AH $13.26 +1.38%
Dr. Reddy's Laboratories LtdStock · HealthcareNifty 50 · 0.8% of INDYEmerging Markets · 0.06% of VWOMSCI ACWI · 0.007% of ACWI
RDY — Dr. Reddy's Laboratories Ltd price, chart and key statistics
Technical analysis2
Overlay lines0
Addendum charts0
VolumeEEESEEEEEEE
6.07.08.09.010.011.012.013.014.015.016.0020.0M$13.26—20162019202120242026
2026-10-20
Price$13.26
MA20$12.83
MA50$13.51
Vol11.3M
Key stats#
Price data
- Price
- $13.26
- YTD price return
- -5.56%
- YTD total return
- -4.89%
- Next earnings
- Oct 23, 2026
- Market cap
- 11.1B
- Enterprise value
- 11.1B
- Shares outstanding
- 834.7M
- 52W low
- $11.36
- 52W high
- $15.67
- From 52W high
- -15.38%
- From 52W low
- +16.73%
- 52W range
- 44%
- Beta
- 0.28
Volume
- Rel volume
- 1.35×
- 30D volume
- 3.1M
- 30D $ vol
- 38.9M
Fundamentals
- Sales (ttm)
- 3.8B
- Sales/share
- $4.55
- EPS (ttm)
- $0.58
- FCF (ttm)
- 316.7M
- FCF/share
- $0.38
- Book value/share
- $4.84
- Net margin
- 12.64%
- ROE
- 11.89%
- ROA
- 7.74%
- Debt / equity
- 0.03×
- Current ratio
- 1.80
Growth (CAGR, ttm) · 10Y
- Sales
- -1.26%+7.44%+8.24%n/a
- Net income
- -29.04%-5.07%+15.64%n/a
- FCF
- -36.25%+7.39%-8.70%n/a
- Shares
- +0.02%+0.08%+0.08%-0.20%
Per-share growth (CAGR, ttm) · 10Y
- EPS
- -27.43%-4.84%+15.79%n/a
- Sales/share
- -1.29%+7.36%+8.16%n/a
- FCF/share
- -36.27%+7.29%-8.78%n/a
- Book value/share
- +3.48%+12.72%+11.20%+7.84%
- Dividend/share
- -4.32%-37.67%+6.07%n/a
- Price
- -10.11%+0.04%+1.00%+3.70%
- Total return
- -9.47%+0.68%+1.87%+4.51%
Fundamentals end at the last reported quarter; price and total return end at the latest close.
Valuation
- P/E (ttm)
- 22.8×
- P/OI (ttm)
- 19.4×
- Fwd P/E
- 20.5×
- P/S (ttm)
- 2.9×
- P/B (mrq)
- 2.7×
- P/FCF (ttm)
- 35.0×
- EV/EBITDA (fy)
- 13.8×
- EV/Sales (ttm)
- 2.9×
- FCF yield (ttm)
- 2.86%
- Dividend yield (fwd)
- 0.63%
- Dividend yield (ttm)
- 0.63%
- Dividend/share (fwd)
- $0.08
- Buyback yield (realized, 1y)
- -0.02%
- Shareholder yield (realized, 1y)
- 0.66%
- Buyback yield (cash, ttm)
- 0.00%
- Shareholder yield (cash, ttm)
- 0.68%
Vs own 10Y history
- P/E
- 37th
- P/OI
- 35th
- P/S
- 24th
- P/B
- 6th
- P/FCF
- 80th
Bar = where today’s multiple sits in RDY’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).
Performance · price return · as of 2026-10-20#
1D
+1.38%
5D
+3.84%
1M
+8.78%
3M
+5.83%
YTD
-5.56%
1Y
-10.10%
5Y
+5.09%
Recent filings#
No earnings release, press release or insider trade outside a 10b5-1 plan in the last 120 days.
All filings and insider trades →Financial statements
Open full RDY financials →Loading financial statements…
Related Healthcare#
| Ticker | Name | 1M | 1D |
|---|---|---|---|
| LLY | Eli Lilly and Company | +11.34% | +3.49% |
| JNJ | Johnson & Johnson | -3.94% | +2.19% |
| ABBV | AbbVie Inc. | +9.52% | +2.26% |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | +11.24% | +3.04% |
| MRK | Merck & Co. Inc. | +0.97% | +3.25% |
| NVS | Novartis AG | +9.45% | +2.29% |
| TMO | Thermo Fisher Scientific Inc. | +5.51% | +1.18% |
| AMGN | Amgen Inc. | +13.82% | +3.29% |
